Performance of BD MAX Group B Streptococcus (GBS) Assay without Enrichment for the Detection of GBS
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Group B streptococcus (GBS) is an important pathogen causing neonatal early-onset disease. We evaluated the diagnostic performance of BD Max GBS assay (Becton Dickinson, Franklin Lakes, NJ, USA) without enrichment (direct BDM) for detecting GBS using vaginal and rectal specimens in comparison with culture. In total, 716 specimens collected from 358 pregnant women between June 2018 and May 2020 were included in this study. Bacterial culture was performed using ChromID Strep B agar (bioMérieux, Marcy-l’Étoile, France), and species identification results were confirmed using the VITEK-MS system (bioMérieux). The sensitivity of direct BDM for vaginal and rectal specimens was 75.0% and 100%, respectively. Thirteen specimens showed discrepant results: 10 false-negative results in the vaginal specimens and three false-positive results in the rectal specimens. The overall agreement between direct BDM and culture was 98.9% (354/358). The final sensitivity and specificity of direct BDM were 98.5% and 99.0%, respectively. Discrepant results—one false-negative and three false-positives—were obtained for four specimens. Direct BDM shows a good diagnostic performance and will be useful for GBS screening within a few hours.
Abstract
Group B streptococcus (GBS) is an important pathogen causing neonatal early-onset disease. We evaluated the diagnostic performance of BD Max GBS assay (Becton Dickinson, Franklin Lakes, NJ, USA) without enrichment (direct BDM) for detecting GBS using vaginal and rectal specimens in comparison with culture. In total, 716 specimens collected from 358 pregnant women between June 2018 and May 2020 were included in this study. Bacterial culture was performed using ChromID Strep B agar (bioMérieux, Marcy-l’Étoile, France), and species identification results were confirmed using the VITEK-MS system (bioMérieux). The sensitivity of direct BDM for vaginal and rectal specimens was 75.0% and 100%, respectively. Thirteen specimens showed discrepant results: 10 false-negative results in the vaginal specimens and three false-positive results in the rectal specimens. The overall agreement between direct BDM and culture was 98.9% (354/358). The final sensitivity and specificity of direct BDM were 98.5% and 99.0%, respectively. Discrepant results—one false-negative and three false-positives—were obtained for four specimens. Direct BDM shows a good diagnostic performance and will be useful for GBS screening within a few hours.
참고문헌 (17)
- Porta K, "Preventing group B streptococcal infections in newborns", JAAPA, 28, pp.24~29 (2015)
- Ahmadzia HK, "Diagnosis and management of group B streptococcus in pregnancy", Obstet Gynecol Clin North Am, 41, pp.629~647 (2014)
- Takashi Takahashi, "Clonal Distribution of Clindamycin-Resistant Erythromycin-Susceptible (CRES) <italic>Streptococcus agalactiae<", italic> in Korea Based on Whole Genome Sequences, 2020, pp.40(5), 370~381[DOI]
- "Prevention of group B streptococcal early-onset disease in newborns: ACOG Committee Opinion, Number 797", Obstet Gynecol, 135, pp.e51~ (2020)[DOI]
- Boyer KM, "Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis", N Engl J Med, 314, pp.1665~1669 (1986)
- Andreasen T, "Comparison of BD MAX GBS and GenomEra GBS assays for rapid intrapartum PCR detection of vaginal carriage of group B streptococci", PLoS One, 14, pp.e0215314~ (2019)
- Verani JR, "Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010", MMWR Recomm Rep, 59, pp.1~36 (2010)
- Van Dyke MK, "Evaluation of universal antenatal screening for group B streptococcus", N Engl J Med, 360, pp.2626~2636 (2009)
- Khalil MR, "Intrapartum PCR assay versus antepartum culture for assessment of vaginal carriage of group B streptococci in a Danish cohort at birth", PLoS One, 12, pp.e0180262~ (2017)
- Schwartz J, "Evaluation of the BD MAX GBS assay to detect Streptococcus group B in LIM broth-enriched antepartum vaginal-rectal specimens", Diagn Microbiol Infect Dis, 73, pp.97~98 (2012)
- Berry GJ, "Comparison of the Panther Fusion and BD MAX Group B Streptococcus(GBS)assays for detection of GBS in prenatal screening specimens", J Clin Microbiol, 57, pp.e01034-19~ (2019)
- Couturier BA, "Antepartum screening for group B Streptococcus by three FDA-cleared molecular tests and effect of shortened enrichment culture on molecular detection rates", J Clin Microbiol, 52, pp.3429~3432 (2014)
- Helmig RB, "Intrapartum PCR-assay for detection of Group B Streptococci(GBS)", Eur J Obstet Gynecol Reprod Biol X, 4, pp.100081~ (2019)
- Riedlinger J, "Multicenter evaluation of the BD Max GBS assay for detection of group B streptococci in prenatal vaginal and rectal screening swab specimens from pregnant women", J Clin Microbiol, 48, pp.4239~4241 (2010)
- Silbert S, "Detection of Group B Streptococcus directly from collected ESwab samples by use of the BD Max GBS assay", J Clin Microbiol, 54, pp.1660~1663 (2016)
- Ellem JA, "Rapid detection of Group B streptococcus directly from vaginal-rectal specimens using liquid swabs and the BD Max GBS assay", Clin Microbiol Infect, 23, pp.948~951 (2017)
- Madani TA, "Screening pregnant women for group B streptococcal colonization", Infection, 26, pp.288~291 (1998)